| 8301 |
Cord Blood |
Allogeneic – Related |
Beta Thalassemia |
Hematology |
2014 |
Standard Therapy |
Germany |
6 |
| 8302 |
Cord Blood |
Autologous |
Cerebral Palsy |
Neurology |
2014 |
Experimental Therapy |
Portugal |
4 |
| 8303 |
Cord Blood |
Autologous |
Cerebral Palsy |
Neurology |
2014 |
Experimental Therapy |
UK |
1 |
| 8304 |
Cord Blood |
Autologous |
Hsv Encephalitis And Nmda Receptor Antibody Encephalitis |
Neurology |
2014 |
Experimental Therapy |
UK |
2 |
| 8305 |
Cord Blood |
Autologous |
Hypoxia-Ischemic Encephalopathy (Hie) |
Neurology |
2014 |
Experimental Therapy |
UK |
3 months |
| 8306 |
Cord Blood |
Allogeneic – Related |
Leukemia |
Hematology |
2014 |
Standard Therapy |
UK |
4 |
| 8307 |
Cord Blood |
Autologous |
Severe Aplastic Anemia |
Hematology |
2014 |
Standard Therapy |
Germany |
11 |
| 8308 |
Bone Marrow Family |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2014 |
Standard Therapy |
Germany |
35 |
| 8309 |
Bone Marrow Family |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2014 |
Standard Therapy |
Germany |
73 |
| 8310 |
Bone Marrow |
Allogeneic |
Non-Hodgkin-Lymphoma-Relapse |
Hematology |
2014 |
Standard Therapy |
Germany |
44 |
| 8311 |
Bone Marrow |
Allogeneic |
Severe Aplastic Anemia |
Hematology |
2014 |
Standard Therapy |
Germany |
60 |
| 8312 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2014 |
Standard Therapy |
Germany |
52 |
| 8313 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2014 |
Standard Therapy |
Germany |
69 |
| 8314 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2014 |
Standard Therapy |
Germany |
51 |
| 8315 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2014 |
Standard Therapy |
Germany |
69 |
| 8316 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2014 |
Standard Therapy |
Germany |
52 |
| 8317 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2014 |
Standard Therapy |
Germany |
29 |
| 8318 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2014 |
Standard Therapy |
Germany |
76 |
| 8319 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2014 |
Standard Therapy |
Germany |
48 |
| 8320 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2014 |
Standard Therapy |
Germany |
53 |
| 8321 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia – Relapse |
Hematology |
2014 |
Standard Therapy |
Germany |
45 |
| 8322 |
Apheresis |
Allogeneic |
Aplastic Anemia |
Hematology |
2014 |
Standard Therapy |
Germany |
27 |
| 8323 |
Apheresis |
Allogeneic |
Aplastic Anemia |
Hematology |
2014 |
Standard Therapy |
Germany |
44 |
| 8324 |
Apheresis |
Autologous |
B-Cell Non-Hodgkin Lymphoma |
Hematology |
2014 |
Standard Therapy |
Germany |
46 |
| 8325 |
Apheresis |
Autologous |
B-Cell Non-Hodgkin Lymphoma – Relapse |
Hematology |
2014 |
Standard Therapy |
Germany |
67 |
| 8326 |
Apheresis |
Autologous |
Bing–Neel Syndrome; Lymphoma |
Hematology |
2014 |
Standard Therapy |
Germany |
64 |
| 8327 |
Apheresis |
Allogeneic |
Chronic Lymphocytic Leukemia |
Hematology |
2014 |
Standard Therapy |
Germany |
42 |
| 8328 |
Apheresis |
Allogeneic |
Chronic Myelogenous Leukemia |
Hematology |
2014 |
Standard Therapy |
Germany |
57 |
| 8329 |
Apheresis |
Allogeneic |
Composite Lymphoma |
Hematology |
2014 |
Standard Therapy |
Germany |
59 |
| 8330 |
Apheresis |
Autologous |
Diffuse Large B-Cell Lymphoma |
Hematology |
2014 |
Standard Therapy |
Germany |
53 |
| 8331 |
Apheresis |
Autologous |
Diffuse Large B-Cell Lymphoma |
Hematology |
2014 |
Standard Therapy |
Germany |
50 |
| 8332 |
Apheresis |
Autologous |
Diffuse Large B-Cell Lymphoma |
Hematology |
2014 |
Standard Therapy |
Germany |
63 |
| 8333 |
Apheresis |
Autologous |
Germ Cell Tumor |
Hematology |
2014 |
Standard Therapy |
Germany |
24 |
| 8334 |
Apheresis |
Autologous |
Lymphoma-Relapse |
Hematology |
2014 |
Standard Therapy |
Germany |
56 |
| 8335 |
Apheresis |
Autologous |
Mantle Cell Lymphoma |
Hematology |
2014 |
Standard Therapy |
Germany |
51 |
| 8336 |
Apheresis |
Autologous |
Mantle Cell Lymphoma |
Hematology |
2014 |
Standard Therapy |
Germany |
62 |
| 8337 |
Apheresis |
Autologous |
Mantle Cell Lymphoma |
Hematology |
2014 |
Standard Therapy |
Germany |
58 |
| 8338 |
Apheresis |
Autologous |
Mantle Cell Lymphoma |
Hematology |
2014 |
Standard Therapy |
Germany |
62 |
| 8339 |
Apheresis |
Autologous |
Mantle Cell Lymphoma |
Hematology |
2014 |
Standard Therapy |
Germany |
51 |
| 8340 |
Apheresis |
Autologous |
Mantle Cell Lymphoma |
Hematology |
2014 |
Standard Therapy |
Germany |
59 |
| 8341 |
Apheresis |
Autologous |
Mantle Cell Lymphoma |
Hematology |
2014 |
Standard Therapy |
Germany |
68 |
| 8342 |
Apheresis |
Allogeneic |
Mantle Cell Lymphoma |
Hematology |
2014 |
Standard Therapy |
Germany |
60 |
| 8343 |
Apheresis |
Autologous |
Marginal Zone Lymphoma |
Hematology |
2014 |
Standard Therapy |
Germany |
52 |
| 8344 |
Apheresis |
Allogeneic |
Morbus Hodgkin |
Hematology |
2014 |
Standard Therapy |
Germany |
31 |
| 8345 |
Apheresis |
Autologous |
Morbus Hodgkin-Relapse |
Hematology |
2014 |
Standard Therapy |
Germany |
44 |
| 8346 |
Apheresis |
Autologous |
Morbus Hodgkin-Relapse |
Hematology |
2014 |
Standard Therapy |
Germany |
37 |
| 8347 |
Apheresis |
Autologous |
Morbus Hodgkin-Relapse |
Hematology |
2014 |
Standard Therapy |
Germany |
19 |
| 8348 |
Apheresis |
Autologous |
Multiple Myeloma |
Hematology |
2014 |
Standard Therapy |
Germany |
70 |
| 8349 |
Apheresis |
Autologous |
Multiple Myeloma |
Hematology |
2014 |
Standard Therapy |
Germany |
71 |
| 8350 |
Apheresis |
Autologous |
Multiple Myeloma |
Hematology |
2014 |
Standard Therapy |
Germany |
60 |
| 8351 |
Apheresis |
Autologous |
Multiple Myeloma |
Hematology |
2014 |
Standard Therapy |
Germany |
71 |
| 8352 |
Apheresis |
Autologous |
Multiple Myeloma |
Hematology |
2014 |
Standard Therapy |
Germany |
66 |
| 8353 |
Apheresis |
Autologous |
Multiple Myeloma |
Hematology |
2014 |
Standard Therapy |
Germany |
60 |
| 8354 |
Apheresis |
Autologous |
Multiple Myeloma |
Hematology |
2014 |
Standard Therapy |
Germany |
53 |
| 8355 |
Apheresis |
Autologous |
Multiple Myeloma |
Hematology |
2014 |
Standard Therapy |
Germany |
59 |
| 8356 |
Apheresis |
Autologous |
Multiple Myeloma |
Hematology |
2014 |
Standard Therapy |
Germany |
60 |
| 8357 |
Apheresis |
Autologous |
Multiple Myeloma |
Hematology |
2014 |
Standard Therapy |
Germany |
30 |
| 8358 |
Apheresis |
Autologous |
Multiple Myeloma |
Hematology |
2014 |
Standard Therapy |
Germany |
64 |
| 8359 |
Apheresis |
Autologous |
Multiple Myeloma |
Hematology |
2014 |
Standard Therapy |
Germany |
70 |
| 8360 |
Apheresis |
Autologous |
Multiple Myeloma |
Hematology |
2014 |
Standard Therapy |
Germany |
77 |
| 8361 |
Apheresis |
Autologous |
Multiple Myeloma |
Hematology |
2014 |
Standard Therapy |
Germany |
52 |
| 8362 |
Apheresis |
Autologous |
Multiple Myeloma |
Hematology |
2014 |
Standard Therapy |
Germany |
60 |
| 8363 |
Apheresis |
Autologous |
Multiple Myeloma |
Hematology |
2014 |
Standard Therapy |
Germany |
69 |
| 8364 |
Apheresis |
Autologous |
Multiple Myeloma |
Hematology |
2014 |
Standard Therapy |
Germany |
63 |
| 8365 |
Apheresis |
Allogeneic |
Multiple Myeloma |
Hematology |
2014 |
Standard Therapy |
Germany |
63 |
| 8366 |
Apheresis |
Allogeneic |
Myelodysplastic Syndrome |
Hematology |
2014 |
Standard Therapy |
Germany |
68 |
| 8367 |
Apheresis |
Allogeneic |
Myelodysplastic Syndrome |
Hematology |
2014 |
Standard Therapy |
Germany |
49 |
| 8368 |
Apheresis |
Allogeneic |
Myelodysplastic Syndrome |
Hematology |
2014 |
Standard Therapy |
Germany |
55 |
| 8369 |
Apheresis |
Allogeneic |
Myelodysplastic Syndrome |
Hematology |
2014 |
Standard Therapy |
Germany |
57 |
| 8370 |
Apheresis |
Allogeneic |
Myeloproliferative Neoplasms |
Hematology |
2014 |
Standard Therapy |
Germany |
56 |
| 8371 |
Apheresis |
Allogeneic |
Myeloproliferative Syndrome |
Hematology |
2014 |
Standard Therapy |
Germany |
60 |
| 8372 |
Apheresis |
Autologous |
Neuroblastoma |
Hematology |
2014 |
Standard Therapy |
Germany |
7 |
| 8373 |
Apheresis |
Autologous |
Non-Hodgkin Lymphoma |
Hematology |
2014 |
Standard Therapy |
Germany |
60 |
| 8374 |
Apheresis |
Allogeneic |
Non-Hodgkin Lymphoma |
Hematology |
2014 |
Standard Therapy |
Germany |
43 |
| 8375 |
Apheresis |
Autologous |
Post-Transplant Lymphoproliferative Disorder |
Hematology |
2014 |
Standard Therapy |
Germany |
60 |
| 8376 |
Apheresis |
Autologous |
Primary Central Nervous System Lymphoma |
Hematology |
2014 |
Standard Therapy |
Germany |
69 |
| 8377 |
Apheresis |
Allogeneic |
Secondary Acute Myeloid Leukemia |
Hematology |
2014 |
Standard Therapy |
Germany |
64 |
| 8378 |
Apheresis |
Allogeneic |
Secondary Acute Myeloid Leukemia |
Hematology |
2014 |
Standard Therapy |
Germany |
42 |
| 8379 |
Apheresis |
Allogeneic |
Secondary Acute Myeloid Leukemia |
Hematology |
2014 |
Standard Therapy |
Germany |
51 |
| 8380 |
Apheresis |
Allogeneic |
Secondary Acute Myeloid Leukemia |
Hematology |
2014 |
Standard Therapy |
Germany |
56 |
| 8381 |
Apheresis |
Allogeneic |
Secondary Acute Myeloid Leukemia |
Hematology |
2014 |
Standard Therapy |
Germany |
75 |
| 8382 |
Apheresis |
Autologous |
Secondary Lymphoma |
Hematology |
2014 |
Standard Therapy |
Germany |
59 |
| 8383 |
Apheresis |
Autologous |
T-Cell Lymphoblastic Lymphoma |
Hematology |
2014 |
Standard Therapy |
Germany |
54 |
| 8384 |
Apheresis |
Autologous |
T-Cell Non-Hodgkin Lymphoma |
Hematology |
2014 |
Standard Therapy |
Germany |
46 |
| 8385 |
Apheresis |
Autologous |
T-Cell Non-Hodgkin Lymphoma |
Hematology |
2014 |
Standard Therapy |
Germany |
48 |
| 8386 |
Apheresis |
Autologous |
T-Cell Non-Hodgkin Lymphoma |
Hematology |
2014 |
Standard Therapy |
Germany |
43 |
| 8387 |
Apheresis |
Allogeneic |
T-Cell Non-Hodgkin Lymphoma Relapse |
Hematology |
2014 |
Standard Therapy |
Germany |
56 |
| 8388 |
Cord Tissue |
Allogeneic – Unrelated |
Acute Graft Versus Host Disease |
Hematology |
2013 |
Experimental Therapy |
Poland |
18,9 |
| 8389 |
Cord Tissue |
Allogeneic – Unrelated |
Acute Graft Versus Host Disease |
Hematology |
2013 |
Experimental Therapy |
Poland |
2,11 |
| 8390 |
Cord Tissue |
Allogeneic – Unrelated |
Acute Graft Versus Host Disease |
Hematology |
2013 |
Experimental Therapy |
Poland |
3,5 |
| 8391 |
Cord Tissue |
Allogeneic – Unrelated |
Acute Myeloid Leukemia |
Hematology |
2013 |
Experimental Therapy |
Poland |
3,5 |
| 8392 |
Cord Tissue |
Allogeneic – Unrelated |
Chronic Graft Versus Host Disease |
Hematology |
2013 |
Experimental Therapy |
Poland |
18,8 |
| 8393 |
Cord Tissue |
Allogeneic – Unrelated |
Chronic Graft Versus Host Disease |
Hematology |
2013 |
Experimental Therapy |
Poland |
17,5 |
| 8394 |
Cord Blood |
Allogeneic – Related |
Acute Lymphoblastic Leukemia |
Hematology |
2013 |
Standard Therapy |
Germany |
8 |
| 8395 |
Cord Blood |
Allogeneic – Related |
Acute Myeloid Leukemia |
Hematology |
2013 |
Standard Therapy |
Poland |
3 |
| 8396 |
Cord Blood |
Allogeneic – Related |
Aplastic Anemia |
Hematology |
2013 |
Standard Therapy |
Poland |
3 |
| 8397 |
Cord Blood |
Allogeneic – Related |
Leukemia |
Hematology |
2013 |
Standard Therapy |
Turkey |
7 |
| 8398 |
Cord Blood |
Allogeneic – Related |
Thalassemia |
Hematology |
2013 |
Standard Therapy |
UK |
5 |
| 8399 |
Cord Blood |
Allogeneic – Related |
Thalassemia Major |
Hematology |
2013 |
Standard Therapy |
Turkey |
7,12 |
| 8400 |
Cord Blood |
Allogeneic – Related |
Thalassemia Major |
Hematology |
2013 |
Standard Therapy |
Turkey |
3 |